1467 related articles for article (PubMed ID: 34304411)
21. Gene editing in dermatology: Harnessing CRISPR for the treatment of cutaneous disease.
Baker C; Hayden MS
F1000Res; 2020; 9():281. PubMed ID: 32528662
[TBL] [Abstract][Full Text] [Related]
22. CRISPR-Cas9 system: A new-fangled dawn in gene editing.
Gupta D; Bhattacharjee O; Mandal D; Sen MK; Dey D; Dasgupta A; Kazi TA; Gupta R; Sinharoy S; Acharya K; Chattopadhyay D; Ravichandiran V; Roy S; Ghosh D
Life Sci; 2019 Sep; 232():116636. PubMed ID: 31295471
[TBL] [Abstract][Full Text] [Related]
23. Development of a CRISPR/Cas9 System for Methylococcus capsulatus
Tapscott T; Guarnieri MT; Henard CA
Appl Environ Microbiol; 2019 Jun; 85(11):. PubMed ID: 30926729
[TBL] [Abstract][Full Text] [Related]
24. RNA-Targeting CRISPR-Cas Systems and Their Applications.
Burmistrz M; Krakowski K; Krawczyk-Balska A
Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32046217
[TBL] [Abstract][Full Text] [Related]
25. Clustered Regularly Interspaced Short Palindromic Repeats/Cas9 Gene Editing Technique in Xenotransplantation.
Naeimi Kararoudi M; Hejazi SS; Elmas E; Hellström M; Naeimi Kararoudi M; Padma AM; Lee D; Dolatshad H
Front Immunol; 2018; 9():1711. PubMed ID: 30233563
[TBL] [Abstract][Full Text] [Related]
26. A Toolkit of CRISPR-Based Genome Editing Systems in Drosophila.
Xu J; Ren X; Sun J; Wang X; Qiao HH; Xu BW; Liu LP; Ni JQ
J Genet Genomics; 2015 Apr; 42(4):141-9. PubMed ID: 25953352
[TBL] [Abstract][Full Text] [Related]
27. CRISPR Cas System: An efficient tool for cancer modelling.
Akhtar M; Jamal T; Khan M; Khan SR; Haider S; Jalil F
J Pak Med Assoc; 2021 Feb; 71(2(B)):718-724. PubMed ID: 33941966
[TBL] [Abstract][Full Text] [Related]
28. Comparative analysis of mouse and human preimplantation development following POU5F1 CRISPR/Cas9 targeting reveals interspecies differences.
Stamatiadis P; Boel A; Cosemans G; Popovic M; Bekaert B; Guggilla R; Tang M; De Sutter P; Van Nieuwerburgh F; Menten B; Stoop D; Chuva de Sousa Lopes SM; Coucke P; Heindryckx B
Hum Reprod; 2021 Apr; 36(5):1242-1252. PubMed ID: 33609360
[TBL] [Abstract][Full Text] [Related]
29. The CRISPR-Cas Mechanism for Adaptive Immunity and Alternate Bacterial Functions Fuels Diverse Biotechnologies.
Newsom S; Parameshwaran HP; Martin L; Rajan R
Front Cell Infect Microbiol; 2020; 10():619763. PubMed ID: 33585286
[TBL] [Abstract][Full Text] [Related]
30. CRISPR/Cas gene therapy.
Zhang B
J Cell Physiol; 2021 Apr; 236(4):2459-2481. PubMed ID: 32959897
[TBL] [Abstract][Full Text] [Related]
31. Novel nucleic acid detection strategies based on CRISPR-Cas systems: From construction to application.
Zhu CS; Liu CY; Qiu XY; Xie SS; Li WY; Zhu L; Zhu LY
Biotechnol Bioeng; 2020 Jul; 117(7):2279-2294. PubMed ID: 32175589
[TBL] [Abstract][Full Text] [Related]
32. CRISPR/Cas9 Immune System as a Tool for Genome Engineering.
Hryhorowicz M; Lipiński D; Zeyland J; Słomski R
Arch Immunol Ther Exp (Warsz); 2017 Jun; 65(3):233-240. PubMed ID: 27699445
[TBL] [Abstract][Full Text] [Related]
33. Optimisation of the clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 : single-guide RNA (sgRNA) delivery system in a goat model.
Huang Y; Ding Y; Liu Y; Zhou S; Ding Q; Yan H; Ma B; Zhao X; Wang X; Chen Y
Reprod Fertil Dev; 2019 Aug; 31(9):1533-1537. PubMed ID: 31079595
[TBL] [Abstract][Full Text] [Related]
34. Genome engineering through CRISPR/Cas9 technology in the human germline and pluripotent stem cells.
Vassena R; Heindryckx B; Peco R; Pennings G; Raya A; Sermon K; Veiga A
Hum Reprod Update; 2016 Jun; 22(4):411-9. PubMed ID: 26932460
[TBL] [Abstract][Full Text] [Related]
35. CRISPR/Cas technology promotes the various application of Dunaliella salina system.
Feng S; Hu L; Zhang Q; Zhang F; Du J; Liang G; Li A; Song G; Liu Y
Appl Microbiol Biotechnol; 2020 Oct; 104(20):8621-8630. PubMed ID: 32918585
[TBL] [Abstract][Full Text] [Related]
36. Development of CRISPR/Cas9 system for targeted DNA modifications and recent improvements in modification efficiency and specificity.
Shin J; Oh JW
BMB Rep; 2020 Jul; 53(7):341-348. PubMed ID: 32580834
[TBL] [Abstract][Full Text] [Related]
37. [CRISPR-Cas9 mediated genome editing in Caenorhabditis elegans].
Meng X; Zhou H; Xu S
Sheng Wu Gong Cheng Xue Bao; 2017 Oct; 33(10):1693-1699. PubMed ID: 29082717
[TBL] [Abstract][Full Text] [Related]
38. Progress on genome-wide CRISPR/Cas9 screening for functional genes and regulatory elements.
Liu SY; Yi GQ; Tang ZL; Chen B
Yi Chuan; 2020 May; 42(5):435-443. PubMed ID: 32431295
[TBL] [Abstract][Full Text] [Related]
39. [Research progress of CRISPR-Cas9 system for gene therapy].
Zhan C; Xia X
Sheng Wu Gong Cheng Xue Bao; 2016 Jul; 32(7):861-869. PubMed ID: 29019208
[TBL] [Abstract][Full Text] [Related]
40. [CRISPR/Cas-based genome editing in Aspergillus niger].
Zheng X; Zheng P; Sun J
Sheng Wu Gong Cheng Xue Bao; 2021 Mar; 37(3):980-990. PubMed ID: 33783162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
